E-Bikes Vroom Forward
Health Care: Drugs
Venaxis Inc (APPY: NASDAQ)
$1.66 0.01 | 0.61%
05/21/13 - 03:59 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 1.66 |
| 52 Week High | 3.96 |
| 52 Week Low | 1.18 |
| Avg. Daily Vol. (Mil) | 0.12 |
| Beta (3 year) | 0.67 |
| Share Related Items | |
| Mkt Cap (Mil) | 16.52 |
| Shares Out (Mil) | 9.95 |
| Float (Mil) | 9.90 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.90 |
| Current Ratio | 3.00 |
| LT Debt/ Equity | 0.09 |
| Total Debt / Equity | 0.32 |
| Valuation Ratios | |
| Price Earnings | 0.30 |
| Price/Sales | 224.80 |
| Price/Book | 1.97 |
| Price/Cash Flow | -1.20 |
| Per Share Data | |
| Earnings | 5.45 |
| Sales | 0.01 |
| Book Value | 0.84 |
| Cash Flow | -1.40 |
| Business Summary | |
|---|---|
| Venaxis Inc advances products that address unmet human diagnostic needs. | |
| General Information | |
| 1585 South Perry Street
Castle Rock, CO 80104 |
|
| venaxis.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 22 | |
| CEO: Stephen T. Lundy | |
| Short Interest | |
| Current Month (Mil) | 0.26 |
| Previous Month (Mil) | 0.25 |
| Short Interest Ratio (Days) | 3.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -105.40 |
| Return on Investments | -157.00 |
| Profitability | |
| Gross Margin | 99.40 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with APPY
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- UserSUPRATRADE-2709091838
- UserBrahmsian's Debt/Equity Por...
- UserBrahmsian's Financially Sou...
- Userdan vosika Portfolio 1
- Usergame on
- Userdreamerl3oi Portfolio 1
- Useremannn Portfolio 1
Latest APPY Headlines from TheStreet
- 5 Biotech Stocks Under $10 Moving Higher 01.30.13 | 08:01 am
- 5 Breakout Stocks: Must-See Charts 12.21.12 | 05:12 pm
- 5 Stocks Under $10 Set to Soar Higher 09.27.12 | 01:09 pm
- 4 Biotech Stocks Under $10 Making Big Moves 09.11.12 | 02:09 pm
- Biotech Sector Weekly Rewind 11.13.10 | 07:11 am
- Vantage Drilling, First M&F: Volume Movers 07.20.10 | 07:07 am
- AspenBio Finds Fault Afar for Failure 07.20.10 | 06:07 am
- Biotech Stock Mailbag: Spectrum Pharma 06.18.10 | 07:06 am
- Hellenic Telecom, AspenBio Pharma: Midday Volume Plays 06.07.10 | 12:06 pm
- Stock Offerings: Navios Maritime 04.30.10 | 11:04 am
Press Releases for APPY
- Venaxis Appoints SomaLogic CMO And Former Pfizer Executive Stephen A. Williams, M.D., Ph.D., To Board Of Directors - PR Newswire 04.18.13 | 04:04 pm
- Venaxis Advances Pivotal U.S. Study And Accelerates European Market Development For APPY1 Blood-based Appendicitis Test - PR Newswire 03.26.13 | 04:03 pm
- Venaxis To Provide Fourth Quarter 2012 Business Update - PR Newswire 03.19.13 | 07:03 am
- Venaxis Secures Additional European Commercial Development Agreements For APPY1 - PR Newswire 03.18.13 | 07:03 am
- Venaxis To Present At 25th Annual ROTH Conference - PR Newswire 03.11.13 | 04:03 pm
- Venaxis Executes First Commercial Development Agreement And Receives Purchase Order From EMELCA Bioscience For Initial EU Launch - PR Newswire 02.07.13 | 07:02 am
- Venaxis Initiates Patient Enrollment For APPY1 Pivotal Study - PR Newswire 01.15.13 | 07:01 am
- Venaxis Obtains CE Mark For APPY1 Appendicitis Test - PR Newswire 01.07.13 | 04:01 pm
- Venaxis Files For CE Mark And Prepares For European Commercialization - PR Newswire 12.21.12 | 07:12 am
- Venaxis Board Appoints Senior Diagnostics Executive To Board Of Directors - PR Newswire 12.20.12 | 04:12 pm
Partner Headlines for APPY
- Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD - GuruFocus 07.09.12 | 01:07 pm
- Weekly Market Wrap: Markets SHAKE, Microsoft's NEW Product, Bank Ratings SLASHED - Wall St. Cheat Sheet 06.23.12 | 09:06 am
- P&G SHAVES Profit Outlook and 4 Hot Stocks to Watch - Wall St. Cheat Sheet 06.20.12 | 12:06 pm
- Market Wrap: Oil SPILLS Lower, Microsoft RALLIES, Operation TWIST - Wall St. Cheat Sheet 06.20.12 | 10:06 am
- Morning Market Losers - Benzinga 06.20.12 | 09:06 am
- Ultimate Market Recap: Iffy Adobe Guidance, Jabil Jumps 7% - Wall St. Cheat Sheet 06.20.12 | 08:06 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 06.19.12 | 09:06 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 06.05.12 | 09:06 am
- Morning Market Losers - Benzinga 12.19.11 | 09:12 am
- AspenBio Pharma Reports AppyScore(TM) ELISA-Based Pivotal Trial Results and Outlines Plans for AppyScore Cassette-Based Test - Benzinga 07.19.10 | 04:07 pm
